Differential effects of nitroblue tetrazolium on the hemodynamic responses elicited by activation of alpha1-adrenoceptors and 5-HT2 receptors in conscious rats

European Journal of Pharmacology
Joy R OwenS J Lewis

Abstract

This study determined the effects of the lipophobic electron acceptor, nitroblue tetrazolium (5 micromol/kg, i.v.) on the vasoconstrictor responses elicited by the 5-hydroxytryptamine2 (5-HT2) receptor agonist, alpha-methyl-5-HT (5-50 microg/kg, i.v.) and the alpha1-adrenoceptor agonist, phenylephrine (2.5-20 microg/kg, i.v.) in conscious Sprague-Dawley rats. The systemic injection of nitroblue tetrazolium elicited pronounced hemodynamic responses that subsided by 10-15 min. Prior to the administration of nitroblue tetrazolium, the injections of alpha-methyl-5-HT and phenylephrine elicited dose-dependent increases in mean arterial blood pressure and mesenteric, renal and hindquarter vascular resistances. After administration of nitroblue tetrazolium, the vasoconstrictor responses elicited by alpha-methyl-5-HT were augmented whereas those elicited by phenylephrine were diminished. These results are consistent with the possibility that nitroblue tetrazolium interacts with the extracellular ligand-binding domains of 5-HT2 receptors and alpha1-adrenoceptor and that this interaction has opposite effects on activities of these G protein coupled receptors.

References

Jan 1, 1976·Progress in Histochemistry and Cytochemistry·F P Altman
Jan 1, 1992·DNA and Cell Biology·W C ProbstS C Sealfon
Oct 1, 1992·Stroke; a Journal of Cerebral Circulation·W I Rosenblum
Jan 1, 1991·Progress in Histochemistry and Cytochemistry·E Seidler
Jan 1, 1991·Annual Review of Neuroscience·D Julius
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Jan 1, 1988·Annual Review of Pharmacology and Toxicology·N K Hollenberg
Feb 6, 1974·Histochemie. Histochemistry. Histochimie·F P Altman
Jan 1, 1970·Histochemie. Histochemistry. Histochimie·F P Altman
Jan 1, 1994·Trends in Pharmacological Sciences·L EmorineA D Strosberg
Sep 7, 1993·European Journal of Pharmacology·R L DavissonS J Lewis
Aug 11, 2000·European Journal of Pharmacology·F S LambS J Lewis
Sep 16, 2000·Hypertension·E J WhalenS J Lewis
Nov 18, 2000·European Journal of Pharmacology·A HoqueS J Lewis
Sep 1, 1955·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·G H FINDLAY
Sep 14, 2004·Journal of Hypertension·Wendy W BatenburgA H Jan Danser
Oct 13, 2005·Journal of Cardiovascular Pharmacology·Stephen J LewisJames N Bates

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.